Federal Territory of Kuala Lumpur, Malaysia, January 19, 2026 -- As artificial intelligence continues to evolve from a ...
The proposed Coordinate-Aware Feature Excitation (CAFE) module and Position-Aware Upsampling (Pos-Up) module both adhere to ...
Researchers from Carnegie Mellon University have discovered a way to target RNA that could lead to new treatment options for ...
The project is part of Build The Earth, a global initiative launched by YouTube creator PippenFTS to recreate the entire ...
Families of four young Texas women killed when an inattentive truck driver hauling H-E-B merchandise rear-ended their vehicle ...
As headwinds emerge in India's home and overseas markets, Shantanu Roy explores how the solar manufacturing sector can ...
Structure Therapeutics (GPCR) just moved its obesity pipeline up a gear by kicking off a first in human Phase 1 trial for ACCG-2671, its oral amylin receptor agonist targeting metabolic disease. See ...
SAN FRANCISCO, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...
The IMCAS test team for the reconfigurable flexible on-orbit manufacturing platform. Credit: IMCAS HELSINKI — A Chinese institute recently completed ground tests on what it describes as a ...
Structure Therapeutics Inc. is a clinical-stage biotech focused on oral GLP-1 drugs for obesity, targeting a rapidly growing sector in pharma market. GPCR's valuation appears attractive given a $1B ...
TypeScript 5.9 has reached the release candidate (RC) stage with enhancements for modern module behavior, hover tooltips, and deferred module evaluation. Microsoft announced the RC on July 25, ahead ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback